Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) Current Leases: 2022-2024

Historic Current Leases for NewAmsterdam Pharma Co N.V (NAMS) over the last 3 years, with Dec 2024 value amounting to $246,000.

  • NewAmsterdam Pharma Co N.V's Current Leases fell 24.58% to $181,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $181,000, marking a year-over-year decrease of 24.58%. This contributed to the annual value of $246,000 for FY2024, which is 310.00% up from last year.
  • NewAmsterdam Pharma Co N.V's Current Leases amounted to $246,000 in FY2024, which was up 310.00% from $60,000 recorded in FY2023.
  • In the past 5 years, NewAmsterdam Pharma Co N.V's Current Leases registered a high of $246,000 during FY2024, and its lowest value of $60,000 during FY2023.
  • Its 3-year average for Current Leases is $124,000, with a median of $66,000 in 2022.
  • In the last 5 years, NewAmsterdam Pharma Co N.V's Current Leases declined by 9.09% in 2023 and then surged by 310.00% in 2024.
  • NewAmsterdam Pharma Co N.V's Current Leases (Yearly) stood at $66,000 in 2022, then dropped by 9.09% to $60,000 in 2023, then surged by 310.00% to $246,000 in 2024.